Finch Therapeutics Group Inc

NASDAQ:FNCH  
1.94
+0.02 (+1.04%)
4:08:28 PM EDT: $1.87 -0.07 (-3.61%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Finch Therapeutics Group Inc Stock, NASDAQ:FNCH

75 State Street, Suite 100, Boston, Massachusetts 02109
United States of America
Phone: +1.617.229.6499
Number of Employees: 1

Description

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.